Why Investors Have Enthusiasm for CureVac N.V.

CureVac N.V. in the News
CureVac N.V. (CVAC) announced that after more than 10 years as a member of the CureVac management board and three years as CEO, Dr. Franz Haas will step down as CEO, effective March 31, 2023.

Joining CureVac from Sanofi, on April 1, 2023, is Dr. Alexander Zehnder.

CureVac is a biopharmaceutical firm developing a new class . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.